Category archive

Pharmaceutical News - page 2

News: Study demonstrates potential of blood test for early lung cancer detection
Pharmaceutical News

Study demonstrates potential of blood test for early lung cancer detection

Oncimmune Holdings plc (AIM: ONC.L), a leading global immunodiagnostics group, welcomes the presentation of data today by Professor Frank Sullivan (Chief Investigator on the ECLS trial) which has demonstrated the potential of Oncimmune’s EarlyCDT® Lung test to reduce the incidence of patients with late-stage lung cancer at diagnosis, compared with standard clinical diagnosis. In a randomised controlled trial of 12,209 people in Scotland at high risk of developing lung cancer, it was shown that more people were diagnosed at an… Keep Reading

Azelis appoints Group Technical Innovation Director, strengthening Azelis’ focus on application and formulation support
Pharmaceutical News

Azelis appoints Group Technical Innovation Director, strengthening Azelis’ focus on application and formulation support

It is with great pleasure that Azelis announces the appointment of Ron Rosenberg as its Group Technical Innovation Director, effective September 1, 2019. This appointment reinforces Azelis’ focus on application and formulation support, and the company’s ambition to become the benchmark in the industry as a fully integrated and innovative solutions provider. Highlights & rationale Azelis appoints its first Group Technical Innovation Director, as a continuation of its efforts to become the industry benchmark as a fully integrated and innovative… Keep Reading

Go to Top